Author

Brianna Gipson

Memorial Sloan Kettering Cancer CenterORCID 0009-0005-5837-8676Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1 Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Organism:mouse· 3 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Approach:statistical model· 2 Research Focus:cell-cell communication· 1 Research Focus:chromatin & epigenetic regulation· 1

Frequent Co-Authors

Kimon V. ArgyropoulosiD· 3 shared Marcel R.M. van den BrinkiD· 3 shared Anastasia I. KousaiD· 2 shared Eric RosiekiD· 2 shared Jonathan U. PelediD· 2 shared Kenton WuiD· 2 shared Marina Burgos da SilvaiD· 2 shared Susan DeWolfiD· 2 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Kimon V. ArgyropoulosORCID

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

MicrobiologyNaturePeer-reviewedSep 30, 2026

Sugar-rich foods exacerbate antibiotic-induced microbiome injury

Anqi Dai, Annamaria Ballweg, William Jogia…·Jonathan U. Peled

The paper links sugar-rich foods to microbiome disruption during antibiotic treatment in patients and mice.

8 citationstop 2%

𝕏 PostBluesky

Cancer BiologybioRxivPreprintMay 9, 2026

Ecological determinants of disease and immunity in myelodysplastic syndromes

Robert F. Stanley, Beatrice D. Zhang, Kimon V. Argyropoulos…·Susan DeWolf

This study uses spatial transcriptomics and single-cell analysis to reveal how MDS bone marrow microenvironments are altered, showing TGFβ dysregulation in malignant cells and immune escape mechanisms.

1 citation

humanspatial transcriptomics

𝕏 PostBluesky

BioengineeringbioRxivPreprintNov 19, 2025

Galectin-3 is a Nanotherapeutic Target in Graft-versus-Host Disease Mediated Kidney Injury

Magdalini Panagiotakopoulou, Ashley N. Sullivan, Kimon V. Argyropoulos…·Daniel A. Heller

The paper identifies galectin-3 as a target for nanotherapeutic delivery of ruxolitinib to reduce GVHD-related kidney injury and systemic inflammation.

DOI 10.1101/2025.11.19.688972

mouseexperimental assay

𝕏 PostBluesky

ImmunologyNature CommunicationsPeer-reviewedJul 4, 2025

An epigenetically distinct HSC subset supports thymic reconstitution

Harold Kunal Elias, Sneha Mitra, Marina Burgos da Silva…·Marcel R.M. van den Brink

This study identifies an epigenetically distinct HSC subset, Kitlo, that supports better thymic and T-cell reconstitution in mice and humans.

7 citationstop 4%

𝕏 PostBluesky